EXCELLA-M SPINAL SYSTEM

{0}------------------------------------------------ # OCT 7 - 2004 # 510(k) Summary of Safety and Effectiveness #### SAFE MEDICAL DEVICES ACT OF 1990 510(k) Summary | Name of Firm: | Innovasis, Inc.<br>997 East 3900 South, Suite 103<br>Salt Lake City, Utah 84124 | |--------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 510(k) Contact: | Brent A. Felix<br>Same address as above | | Trade Name: | 'Excella-M' Spinal System | | Common Name: | Rod and Screw Spinal Instrumentation | | Classification: | Spinal Intervetebral Body Fixation Orthosis (21 CRF 888.3060)<br>Spinal Interlaminal Fixation Orthosis (21 CFR 888.3050)<br>Spondylolisthesis Spinal Fixation System (21 CRF 888.3070)<br>Pedicle Screw Spinal System (21 CRF 888.3070) | | Device Product Code: | KWQ, KWP, MNH, MNI. The Panel code is 87. | | Substantially<br>Equivalent Devices: | Blackstone Spinal Fixation System (k994217)<br>DePuy Acromed Moss Miami system (k992168)<br>Synthes Universal Spinal System (k990745)<br>Interpore Cross Synergy IQ Spinal System (k012871) | #### Device Description: The INNOVASIS 'Excella-M' Spinal System is a 6-4 Titanium Alloy device comprised of a variety of non-sterile, single use components of 2 size diameters (6.5 & 7.5mm) and various lengths of monoaxial Pedicle Screws with an assortment of various lengths 6.0mm Rods. The INNOVASIS 'Cross Link' is a modification to the 'Excella-M' Spinal System that allows the surgeon to build a spinal implant construct to increase rotational stability. The system is attached to the vertebral body by means of screws to the non-cervical spine. The INNOVASIS 'Excella-M' Spinal System consists of an assortment of screws, rods, cross-connector and related instrumentation as implant offerings specific to this system. {1}------------------------------------------------ ## Intended Use: The Innovasis 'Excella-M' Spinal System is intended for use in the non-cervical area of the spine. #### Indications for use are as follows: The INNOVASIS 'Excella-M' Spinal System, when used for pedicle screw fixation is intended only for patients: - a) Having severe spondyloysthesis (Grade 3 & 4) at the L5-S1 joint; - b) Who are receiving fusion using autogenous bone graft only; - c) Who are having the device fixed or attached to the lumbar and sacral spine (1.3 and below): and - d) Who are having the device removed after the development of a solid fusion mass. The INNOVASIS 'Excella-M' Spinal System, when used as a pedicle screw system in skeletally mature patients, is intended to provide immobilization and stabilization of spinal segments, as an adjunct to fusion, in treatment of the following acute and chronic deformities of the thoracic, lumbar, and sacral spine: - Degenerative spondylolisthesis with objective evidence of neurologic a) Fracture; c) Dislocation; d) Scloiosis; e) Kyphosis; f) impairment b) Spinal tumor, and g) Previous failed fusion (pseudarthrosis). The INNOVASIS 'Excella-M' Spinal System, when used for anterolateral non-pedicle fixation, is intended for the following indications: - Degenerative disc disease (as defined as back pain of discogenic origin with a) degenerative disc confirmed by patient history and radiographic studie); - b) Spinal stenosis; c) Spondylolisthesis; d) Spinal deformities (i.e., scloliosis, kyphosis, and/or lordosis). - e) Pseudarthrosis; f) Tumor; g) Trauma (i.e. fracture or dislocation); and - h) Previous failed fusion. The INNOVASIS 'Excella-M' Spinal System, when used for posterior non-pedicle screw fixation to the non-cervical spine, is intended for the following indications: - a) Degenerative disc disease (defined as back pain of disogenic origin with degenerative disc confirmed by patient history and radiographic studies); - b) Spinal stenosis; c) Spondylolisthesis; d) Spinal deformities (i.e. scolosis, kyphosis and/or lordosis); - e) Pseudoarthrosis; f) Tumor; g) Trauma (i.e. fracture or dislocation); and - h) Previous failed fusion. {2}------------------------------------------------ <042143 ## Material: The Innovasis 'Excella-M' Spinal System is made from 6-4 Alloy Titanium (ASTM F 136). These materials are proven to be biocompatible as implant materials. ## Performance Data: Mechanical testing in accordance with the "Guidance for Industry and FDA Staff Spinal System 510(k)s", issued May 3, 2004 was presented. ### Basis of Substantial Equivalence: The Innovasis 'Excella-M' Spinal System is similar to the predicate the Blackstone Spinal Fixation System (k994217), DePuy Acromed Moss Miami System (k992168), Synthes Universal Spinal System (k990745), and Interpore Cross Synergy IQ Spinal System (k012871) with respect to technical characteristics and performance. ### Summary of Safety and Effectiveness: The Innovasis 'Excella-M' Spinal System is shown to be safe and effective for use in certain antierior and pedicle fixation use indications. {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three lines representing its wings. The eagle is positioned to the right of a circular text element that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT 7 - 2004 Mr. Brent A. Felix President Innovasis, Inc. 997 East 3900 South, Suite 103 Salt Lake City, Utah 84124 Re: K042143 Trade/Device Name: ' Excella-M' Spinal System Trade/Device Name: "Excella II "Special In "Special", 21 CFR 888.3070 Regulation Name: Spinal interlaminal fixation orthosis, Spinal intervertebral body fixation orthosis, Pedicle screw spinal system Regulatory Class: II Product Code: KWQ, KWP, MNH, MNI Dated: July 30, 2004 Received: August 9, 2004 Dear Mr. Felix: We have reviewed your Section 510(k) premarket notification of intent to market the device we have teviewed your bected. 9 1 ( ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } felerenced above and nave determined in the enclicate devices marketed in interstate for use stated in the encrosure) to regars and ment date of the Medical Device Amendments, or to commerce prior to May 20, 1978, the eccordance with the provisions of the Federal Food. Drug. devices that have been receasemed in a proval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I ou may, merciole, market the device, solo, solo, exceptements for annual registration, listing of general controls proficiouring practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (500 a0070) als. Existing major regulations affecting your device can may be subject to such additional controls. Existing major regulations an may be subject to suell additional connections, Title 21, Parts 800 to 898. In addition, FDA may be found in the Our acements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Flease be advised that I Dri- blocation of the complies with other requirements of the Act that 1127 has made a acterinalistions administered by other Federal agencies. You must or any I caean statutes and registements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set {4}------------------------------------------------ Page 2 -- Mr. Brent A. Felix forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic forth in the quality systems (Sections (Sections 531-542 of the Act); 21 CFR 1000-1050. product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will allow you to begin marketing your antial equivalence of your device to a legally premarket notification. The FDA finding of substantial equivale vour devi premarket notification. The PDA Intellig of substantial equal and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (1 CFR Part 801), please on the later an intelled If you desire specific advice for your act (240) 276-0120. Also, please note the regulation entitled, Contact the Office of Comphalled at (210) 210 cation" (21CFR Part 807.97). You may obtain " Whisbranding by responsibilities to premained in the Act from the Division of Small other general International onlyour responsibilities and its toll-free number (800) 638-2041 or Manufacturers, International and Ochbankt Proventifdsma/dsmamain.html Sincerely yours, Sincerely yours, Mark McMillan Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ INNOVASIS, INC. Salt Lake Ciry Urah ## Indications for Use 510(k) Number: K042143 Device Name: 'Excella-M' Spinal System Indications for Use: The Innovasis 'Excella-M' Spinal System is intended for use in the non-cervical area of the spine. The Innovasis 'Excella-M' Spinal System, when used for pedicle screw fixation is intended only for patients: - a) Having severe spondylolisthesis (Grade 3&4) at the LS-S1 joint; - Who are receiving fusion using autogenous hone graft only; し) - Who are having the device fixed or attached to the lumbar sacral spinc (L3 and below); and c) - Who are having the device removed after the development of a solid fusion mass. () The Innovasis 'Excella-M' Spinal System, when used as a pedicle screw system in skeletally mature patients, is intended to provide inunobilization and stabilization of spinal segments, as an adjunct to fusion, in treatment of the following acute and chronic deformities of the thoracic. lumbar, and sacral spine: a) Degenerative spondylolisthesis with objective evidence of neurologic impairment; b) Fracture; c) Dislocation; d) Scoliosis; e) Kyphosis; f) Spinal tumor; and g) Previous failed fusion (pseudarthrosis). The Innovasis 'Excella-M' Spinal System, when used for anterolateral non-pedicle fixation, is intended for the following indications: a)Degenerative disease (DDD) ( defined as back pain of discogenic origin with degenerative disc confirmed by patient history and radiographic studies); b) Spondylolisthesis; d) Spondylolisthesis; d) Spinal deformities (i.e. scollosis, kyphosis, and/or lordosis); e) Pseudarthrosis; 1) Tumor: g) Trauma (i.e. fracture or dislocation); and h) Previous failed fusion. The Innovasis *Excella-M' Spinal System, when used for posterior non-pedicte screw fixation to the noncervical spine, is intended for the following indications: a) Degenerative disc disease (DDD) (defined as back pain of discogenic origin with degenerative disc confirmed by patient history and radiographic studies); b) Spinal stenosis; c) Spondylolisthesis; d) Spinal deformities (i.e. scoliosis, kyphosis and/or lordosis); e) Pseudarthrosis; 1) Tumor; g) Trauma (i.e. fracture or dislocation); and h) Previous failed fusion | Prescription Use | X | |-----------------------------|--------| | (Part 21 CFR 801 Subpart D) | AND/OR | Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Mark N Millken Page 1 of 1 Division of General, Restorative, and Neurological Devices 510(k) Number K042143